Pfizer (PFE 0.66%) received U.S. Emergency Use Authorization (EUA) for its COVID-19 vaccine on Dec. 11, 2020. This has raised hopes that Moderna (MRNA 1.58%) could soon win EUA for its coronavirus vaccine as well. In this Motley Fool Live video recorded on Dec. 11, healthcare and cannabis bureau chief Corinne Cardina talked with immunotherapy scientist Dr. Leo Nissola about the potential for Pfizer's vaccine authorization to improve Moderna's chances of receiving an EUA for its vaccine.

10 stocks we like better than Moderna INC
When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.*

David and Tom just revealed what they believe are the ten best stocks for investors to buy right now... and Moderna INC wasn't one of them! That's right -- they think these 10 stocks are even better buys.

See the 10 stocks

 

*Stock Advisor returns as of November 20, 2020

 

Corrine Cardina: Do you see this as a sign that the Moderna vaccine candidate will also get the green light?

Dr. Leo Nissola: Well, first, I think that Moderna's vaccine has everything on positive to actually occur. So I do agree that Pfizer's vaccine being approved will mean that perhaps the data coming in from Moderna will also be positive.

But I haven't looked at the raw clinical data from those patients so I can't speak on behalf of Moderna. They are also a different company. They have a different history and we can't speak about Moderna with that amount of confidence right now.

Corrine Cardina: Absolutely. The FDA Advisory Committee will be convening next Thursday to look at that. So we will keep everyone posted with anything that comes out of that.